What are exosomes? For many years, exosomes were considered to be transporters of cellular waste, but they are now recognized for their essential role in intercellular communication and transportation.
In this article:
- Definition of Exosomes
- Exosome Size
- Exosome Sources
- Exosome Characteristics
- Exosome Review
- Exosome Research
- Cancer Exosomes
- Exosome Therapeutics
- First EV Therapeutic Entering Human Trial
- Exosome Market
Definition of Exosomes
Exosomes are defined as small vesicles ranging from 30-100nm in size that are found in nearly all eukaryotic fluids and facilitate a range of important cellular functions. They transfer DNA, RNA, and proteins to other cells, thereby altering the function of the target cells.
The diameter of exosomes can range from 30 nm on the low end to 150 nm on the high end. Because exosomes have a low refractive index and are less than 150 nm in diameter, the separation of exosomes from similar sized cells and vesicles can be a challenge.
For this reason, the isolation of pure populations of exosomes may involve physical techniques based on size and density, as well as techniques that utilize biochemical parameters.
Exosomes are present in nearly all body fluids, including:
- Synovial fluid
- Amniotic fluid
- Vaginal fluid
- Breast milk
- Serum and plasma from cancer patients
- Cultured medium of cell cultures
- And more
Exosomes are characterized by the following features:
- Range from 30-100nm in size
- Found in nearly all bodily fluids
- Exported by all eukaryotic cell types
- Exosome properties reflect the donor cell
- Produced in extremely abundant amounts
A review of exosome activity reveals that there has been a explosion in scientific research in recent years. For decades, exosomes were considered extracellular byproducts, but these nano-sized vesicles are now becoming increasingly recognized for their critical role in intercellular communication for both healthy and diseased cell types.
Exosomes have an extraordinary ability to transfer proteins, DNA, mRNA, non-coding RNAs.
Substantial research suggests that understanding the role of cancer exosomes will be critical to the future of human health, because exosomes have the potential to be used in cancer prevention, diagnosis, and therapeutic care.
Exosome research are being rapidly explored within academic research settings and private industry. When exosome publications are analyzed, U.S. authors have published approximately 40% of the articles and China takes second place.
However, when the term “exosome” is searched in the scientific literature, Dr. Susanne Gabrielsson from the Karolinska Institutet in Sweden is the leading author with 37 articles.
When the term “extracellular vesicles” is searched, Unicyte AG, a regenerative medicine unit of Fresenius Medical Care, takes the lead. The company has published 100+ papers on exosomes and extracellular vesicles in collaboration with Professor Giovanni Camussi.
Exosomes are released in high quantities from rapidly growing cells, including all forms of cancer. It is known that cancer exosomes contribute to metastasis through intercellular communication. Although exosomes are produced by all cells to facilitate bodily functions, on a cell-for-cell basis, cancer cells release larger quantities of exosomes.
Cancer exosomes are also unique, because they are surrounded by protein “ribbons” known as chaperones. While these ribbons can vary in size and shape on the surface of exosomes from different types of rapidly growing cells, they are always present.
Because exosomes exhibit biomarkers specific to the cancerous cells that have released them, exosomes also have great potential to be used within theranostic applications. Theranostics is a field of medicine that provides patient-specific therapy based on findings from targeted diagnostic tests. Finally, cancer exosomes have great potential to be used within diagnostic tools and liquid biopsies for non-invasive detection of cancer.
There are three common applications of exosomes in cancer, which are:
- Exosomes facilitate cancer activity, including tumor formation (tumorigenesis), spread (metastasis), blood vessel growth (angiogenesis), and immune evasion.
- Cancer exosomes can be used as biomarkers within diagnostic tools.
- Cancer exosomes can be used to select targeted treatments for cancer patients based on their unique disease progression.
Recently, exosomes have been gaining momentum within the medical research community as a type of cell-free therapeutic. Numerous approaches are being researched for creating drug-loaded exosomes and exosomes themselves can exert powerful effects. For example, mesenchymal stem cell (MSC) derived exosomes have the capacity to suppress inflammation, prevent scar tissue formation, and mediate a healthy immune response.
Similarly, if a patient has a disease caused by a missing or defective protein or microRNA, the patient’s exosomes can be isolated, modified with the appropriate siRNA or protein, and injected back into the patient for treatment.
Today, dozens of companies from across the globe are developing exosome therapeutics.
First EV Therapeutic Entering Human Trial
Aegle Therapeutics deserves recognition as the first extracellular vesicle (EV) company to be cleared by the FDA to enter clinical trials in humans. In May 2018, Aegle announced that the FDA had cleared its first Investigational New Drug (IND) application to initiate a clinical trial in severe second degree burn patients. The company launched a Phase 1/2a clinical trial of its lead product AGLE-102 in late 2018.
Aegle is utilizing allogeneic bone marrow mesenchymal stem cell (BM-MSC) derived extracellular vesicles. It has two products under development, AGLE-102 for burn treatment and AGLE-103 for the management of epidermolysis bullosa (EB).
Exosome-related technologies have been developing rapidly over the past few years and substantial growth is expected for the market as they get integrated into the fields of liquid biopsy, precision medicine and regenerative medicine. In particular, cancer derived exosomes influence the invasive potential of cells by regulating angiogenesis, metastasis, and immunity, making them an extremely useful source of biomarkers for use in cancer detection, diagnosis, and therapeutic selection.
To characterize the rapidly expanding exosome market, BioInformant released a 274-page report that explores growing demand for exosome therapeutics, diagnostics, research tools, and manufacturing technologies. It reveals trend rate data for exosome patents, grants, scientific publications, and clinical trials, as well as features company profiles for 107 global competitors.
Of course, it presents market size determinations by market segment with forecasts through 2028.